TAVI: PLC Systems launches RenalGuard trial

September 16, 2013 by Sony Salzman

PLC Systems treats the 1st patient with its RenalGuard in a trial to evaluate the device in patients with acute kidney failure undergoing heart valve replacement procedures.

TAVI: PLC Systems launches RenalGuard trial

PLC Systems (PINK:PLCSF) said its RenalGuard device was used in a new clinical trial evaluating the device in treating patients with acute kidney failure undergoing transcatheter aortic valve implantation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp